Bone marrow cell kinetics in primary myelodysplastic syndromes
Montecucco, C.; Riccardi, A.; Ascari, E.
Haematologica 72(6 Suppl): 132-134
1987
ISSN/ISBN: 0390-6078 PMID: 3127290 Document Number: 294020
Document emailed within 1 workday
Related Documents
Werner, M.; Maschek, H.J.; Kaloutsi, V.; Buhr, T.; Kausche, F.; Delventhal, S.; Georgii, A. 1990: Cytogenetic examination of bone marrow cells in stem cell diseases of myelodysplastic syndromes Verhandlungen der Deutschen Gesellschaft für Pathologie 74: 139-143De Witte, T.; Zwaan, F.; Hermans, J.; Vernant, J.; Kolb, H.; Vossen, J.; Lönnqvist, B.; Beelen, D.; Ferrant, A.; Gmür, J. 1989: Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) Bone Marrow Transplantation 4(Suppl 3): 38-39
Li, L.-j.; Fu, R.; Wang, H.-q.; Yue, L.-z.; Liu, H.; Wang, J.; Wang, H.-l.; Ruan, E.-b.; Qu, W.; Liang, Y.; Wang, G.-j.; Wang, X.-m.; Liu, H.; Song, J.; Wu, Y.-h.; Xing, L.-m.; Guan, J.; Shao, Z.-h. 2010: Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances Zhonghua Yi Xue Za Zhi 90(10): 672-677
Kitagawa, M.; Saito, I.; Kuwata, T.; Yoshida, S.; Yamaguchi, S.; Takahashi, M.; Tanizawa, T.; Kamiyama, R.; Hirokawa, K. 1997: Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes Leukemia 11(12): 2049-2054
Oluwole, S.F.; Engelstad, K.; Hardy, M.A. 1992: Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum Transplantation Proceedings 24(6): 2858-2859
Hantaweepant, C.; Chinthammitr, Y.; Khuhapinant, A.; Sukpanichnant, S. 2016: Clinical Significance of Bone Marrow Involvement as Confirmed by Bone Marrow Aspiration vs. Bone Marrow Biopsy in Diffuse Large B-cell Lymphoma Journal of the Medical Association of Thailand 99(3): 262-269
Greenberg, P.L. 1996: Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes Seminars in Hematology 33(2): 163-175
Knott, L.J.; Levinsky, R.J.; Newland, A.C.; Jones, H.M.; Linch, D.C. 1985: Bone marrow T cell colony-forming cells: studies of their origin and use in monitoring T cell-depleted bone marrow grafts Clinical and Experimental Immunology 62(3): 561-569
Tsurusawa, M.; Sasaki, K.; Matsuoka, H.; Katano, N.; Fujimoto, T. 1985: Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(9): 1827-1832
De Witte, T. 1999: Stem cell transplantation in myelodysplastic syndromes Forum 9(1): 75-81
Rugal', V.I.; Ponomarenko, V.M.; Shatseva, T.A.; Abdulkadyrov, K.M. 1995: Morphologic features of bone marrow in myelodysplastic states Voprosy Onkologii 41(1): 52-55
Panani, A.D.; Pappa, V. 2005: Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes In Vivo 19(6): 979-981
Sanz, C.; Richard, C.; Prosper, F.; Fernandez-Luna, J.L. 2002: Nuclear factor k B is activated in myelodysplastic bone marrow cells Haematologica 87(9): 1005-1006
Kang, H.Y.; Wang, C.B. 2016: The significance of clinical-examination communication in the total process of bone marrow cell morphology and bone marrow biopsy Zhonghua Yi Xue Za Zhi 96(24): 1884-1887
Jackson, G.H.; Clarke, A.J.; Taylor, P.; Dickinson, A.M.; Proctor, S.J.; Cattan, A.R. 1991: Supernatant cell counts from long-term bone marrow culture correlate with the speed of engraftment following autologous bone marrow transplantation Bone Marrow Transplantation 8(6): 439-444
Shalit, M.; Ayalon, M.; Weiss, L.; Leshem, B.; Kedar, E.; Slavin, S. 1986: Bone marrow transplantation with T-cell-depleted grafts. I. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted syngeneic bone marrow grafts Transplantation 42(2): 118-122
Matzner, Y.; Polliack, A. 1981: Bone marrow curettage in myelodysplastic disorders. a stimulus for regeneration in disturbed hematopoiesis JAMA 246(17): 1926-1928
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016
de Witte, T.; Brand, R.; van Biezen, A.; Delforge, M.; Biersack, H.; Or, R.; Meloni, G.; Bandini, B.; Sierra, J.; Kroger, N.; Gratwohl, A.; Niederwieser, D. 2006: The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes Haematologica 91(6): 750-756
Appelbaum, F.R.; Anderson, J. 1998: Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score Leukemia 12(Suppl 1): S25-S29